Fan Jin
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Development and validation of tools for predicting the risk of death and ICU admission of non-HIV-infected patients with Pneumocystis jirovecii pneumonia.
Journal: Frontiers in public health
Published: June 18, 2022
Lymphocyte subset analysis to evaluate the prognosis of HIV-negative patients with pneumocystis pneumonia.
Journal: BMC infectious diseases
Published: February 09, 2021
Comparing Smartphone Apps for Traditional Chinese Medicine and Modern Medicine in China: Systematic Search and Content Analysis.
Journal: JMIR mHealth and uHealth
Published: January 25, 2021
Reply to: Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 07, 2020
High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 01, 2019
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) associated with or without lymphoma: Comparison of clinical features and risk factors suggestive of underlying lymphomas.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: March 01, 2019
Peripheral T cell lymphoma after chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): a case report.
Journal: BMC neurology
Published: January 01, 2019
Pharmacokinetics and pharmacodynamics of a polyethylene glycol (PEG)-conjugated GLP-receptor agonist once weekly in Chinese patients with type 2 diabetes.
Journal: Journal of clinical pharmacology
Published: April 20, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026